{"schema_version":"secwatch.filing_event.v1","accession":"0000049071-26-000021","form_type":"8-K","ticker":"HUM","cik":"0000049071","company_name":"HUMANA INC","filed_at":"2026-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:33.605373+00:00","generated_at":"2026-05-15T02:32:16.963655+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Humana 1Q26 adj EPS $10.31; affirms FY adj EPS at least $9.00; revises GAAP guidance down","bullets":["1Q26 GAAP EPS $9.83, Adjusted EPS $10.31 (high end of ~110-115% of FY); 1Q25 GAAP $10.30, Adj $11.58.","Revenue $39.6B vs $32.1B YoY; Insurance benefit ratio 89.4% (guidance 'just under 90%').","Affirms FY2026 adjusted EPS guidance at least $9.00; revises GAAP EPS to at least $8.36 from at least $8.89.","CenterWell added 110,500 patients sequentially (+22%), incl. ~59,000 from MaxHealth acquisition; state contracts membership up ~50,000.","Insurance President George Renaudin to retire June 29, 2026; Aaron Martin to succeed, John Barger to lead Medicare Advantage."],"urls":{"canonical":"https://secwatch.observer/filing/0000049071-26-000021","json":"https://secwatch.observer/filing/0000049071-26-000021.json","markdown":"https://secwatch.observer/filing/0000049071-26-000021.md","text":"https://secwatch.observer/filing/0000049071-26-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/49071/000004907126000021/0000049071-26-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/49071/000004907126000021/hum-20260429.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T02:32:16.963655+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"791e49b1d9ee7caca4742ac676930a50cacd54a3","claim":"HUMANA INC reported the quarter ended March 31, 2026 results: EPS $9.83.","evidence_excerpt":"Reports 1Q26 earnings per share (EPS) of $9.83 on a GAAP basis, Adjusted EPS of $10.31","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907126000021/0000049071-26-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2026"},{"label":"EPS","value":"$9.83"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"98616186420f052c04e6e2d052d7f5f4f04d0ddf","claim":"HUMANA INC reported the year ending December 31, 2026 results: EPS at least $9.00. Guidance reaffirmed.","evidence_excerpt":"Affirms Adjusted FY 2026 GAAP EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $8.36' from the previous estimate of 'at least $8.89'","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/49071/000004907126000021/0000049071-26-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ending December 31, 2026"},{"label":"EPS","value":"at least $9.00"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}